TARO PHAR.INDS. IS 0,0001
TARO PHAR.INDS. IS 0,0001/ IL0010827181 /
TAL
|
28/05/2024 08:03:37
|
Chg.
-0.2000
|
Volume |
Bid15:30:14 |
Demandez à15:30:14 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
39.0000EUR
|
-0.51%
|
0
Chiffrre d'affaires: 0.0000 |
39.2000Bid taille: 300 |
39.4000Ask la taille: 300 |
1.47 Mrd.EUR |
- |
- |
Description de l'entreprise
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.
Conseil d'administration & Conseil de surveillance
| PDG |
| Uday Baldota |
| Conseil d'administration |
| William J. Coote, Vikash Agarwal, Avi Avramoff, Victoria Chester, Anthony Dolan, Moshe Gavrilov, Nivaran Kapur, David Kinzelberg, Karen Lowney, Barb Pimentel, Hagai Reingold, Michele Visosky, Erik Zwicker |
| Conseil de surveillance |
| Dilip Shanghvi, Abhay Gandhi, Uday Baldota, Linda Benshoshan, James Kedrowski, Dr. Robert Stein, Sudhir Valia |
Données de l'entreprise
| Nom: |
Taro Pharmaceutical Industrie |
| Adresse: |
14 Hakitor Street, Haifa Bay,Haifa 2624761 |
| Téléphone: |
+972 4 847 5700 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
https://www.taro.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
30/03 |
| Flotte libre: |
- |
| IPO date: |
01/01/1961 |
